{
    "Disease Activity (follow up: 4 months; assessed with: ACR 20)": {
        "No of studies": "1",
        "Study design": "randomised trials",
        "Risk of bias": ["not serious", "a"],
        "Inconsistency": "not serious",
        "Indirectness": "not serious",
        "Imprecision": ["serious", "b"],
        "Other considerations": "none",
        "Nº of patients": {
            "SC MTX": "160/188 (85.1%)",
            "Oral MTX": "144/187 (77.0%)"
        },
        "Effect": {
            "Relative (95% CI)": "RR 1.11 (1.00 to 1.22)",
            "Absolute (95% CI)": "85 more per 1,000 (from 0 fewer to 169 more)"
        },
        "Certainty": "⨁⨁⨁◯ MODERATE",
        "Importance": "CRITICAL"
    }
}